Lakshmana Madala, MD
Pain Medicine · Saginaw, MINPI 1093742637
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. Abbott accounts for 88.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $1,118 and has fallen 71.8% since, to $315 in 2025. That places this record below the midpoint for pain medicine clinicians in MI, where the typical reported total is $1,927.
Across 67 payments — averaging $30.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Stimwave Technologies Incorporated$109
- Vertos Medical, Inc.$43
- Stryker$36
- Boston Scientific$27
- Tersera Therapeutics LLC$27
What the payments were for
- Travel & lodging$77238%
- Food & beverage$1,17357%
- Education$1075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 60 | $1,811 |
| Stimwave Technologies Incorporated | 1 | $109 |
| Vertos Medical, Inc. | 1 | $43 |
| Stryker | 2 | $36 |
| Boston Scientific | 1 | $27 |
| Tersera Therapeutics LLC | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,052 in reported general payments places this provider in the 50th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $232 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Saginaw
- Caleb OrtegaSaginaw$8K
- Matthew EaglesonSaginaw$7K
- Harry SukumaranRochester Hills$304K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$44K
- Alexander TurfeWyandotte$41K
- Kendall GroseWyandotte$26K
- Craig HartrickRoyal Oak$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.